stockrow
Saturday 7 November 2026
Export SRTA’s income statement to Excel — free account
Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
- Revenue
- +50.3%
- EPS
- −112.3%
- Free cash flow
- +121.3%
Quarter to September 2026, against a year earlier
5.57
0.31
+5.89%
Follow SRTA
Alert me
| Sep '19 | Dec '19 | Sep '20 | Dec '20 | Sep '21 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | 4 | 5 | 5 |
P/E ratio |
491.50 | — | 15.45 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.49 |
Altman Z-Score |
— | — | 19.91 | — | 5.80 | 5.68 | 3.19 | 2.51 | 5.60 | 5.25 |
P/S ratio |
0.00 | — | 0.00 | — | 12.00 | 5.04 | 1.65 | 1.11 | 1.72 | 2.00 |
P/FCF ratio |
0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | (6.03) | — | 10.48 | 10.95 | 7.42 | 4.54 | 7.27 | 6.54 |
P/Operating CF |
(48,922.50) | — | 8.69 | — | (123.94) | (62.93) | (26.45) | (26.90) | (188.00) | (47.53) |
Beneish M-Score |
— | — | — | — | (1.31) | — | (1.02) | (2.42) | (2.22) | (0.84) |
P/B ratio |
12.72 | — | 7.45 | — | 2.46 | 1.30 | 0.88 | 1.07 | 1.48 | 1.41 |
Price to Tangible BV |
12.72 | — | 7.83 | — | 2.71 | 1.49 | 1.28 | 1.45 | 1.66 | 2.75 |
EV/Sales |
0.00 | — | 0.00 | — | 6.91 | 1.28 | 0.31 | 0.37 | 1.07 | 1.69 |
EV/EBITDA |
0.00 | — | 3.91 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | — | (104.74) | — | (25.82) | (4.44) | (1.23) | (2.58) | (81.10) | (6.82) |
EV/FCF |
0.00 | — | (104.74) | — | (24.82) | (4.34) | (1.20) | (2.43) | (5.75) | (5.56) |
Quick Ratio |
1,191.20 | 3.52 | 2.11 | 2.17 | 32.37 | 22.54 | 7.74 | 5.31 | 6.38 | 5.13 |
Current Ratio |
1,191.20 | 3.85 | 2.27 | 2.29 | 32.99 | 23.07 | 8.20 | 5.81 | 7.07 | 6.38 |
Net Debt/EBITDA |
24.86 | 4.87 | 1.25 | 1.25 | 12.97 | 8.48 | 4.08 | 2.74 | 7.55 | 4.34 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.23 | 0.00 | 0.16 | 0.00 | 0.16 | 0.22 | 0.44 | 0.73 | 0.53 | 0.68 |
Operating CF/Net income |
0.95 | (0.33) | 1.06 | (6.22) | 0.39 | 0.55 | 1.36 | 0.58 | 0.09 | (1.18) |
Capex/Depreciation |
(1.28) | — | (0.72) | — | (0.50) | (9.81) | (0.13) | (0.28) | (5.53) | (1.35) |
| 0.00% | 27.13% | (126.37%) | 1.59% | (27.04%) | (13.48%) | (9.63%) | (22.04%) | (11.97%) | 16.51% | |
| (7.88%) | 0.28% | (6.88%) | 0.09% | (12.89%) | (11.57%) | (8.25%) | (18.09%) | (9.90%) | 14.21% | |
ROIC |
0.00% | (4.54%) | 0.00% | (10.21%) | 0.00% | (246.73%) | (42.17%) | (63.53%) | (14.54%) | (6.42%) |
Return on Tangible Assets |
(3.94%) | 74.09% | (103.74%) | 25.27% | (13.05%) | (13.82%) | (14.08%) | (32.29%) | (16.40%) | 28.95% |
Average Days of Receivables |
0.00 | — | 17.01 | — | 27.20 | 26.95 | 27.17 | 34.05 | 49.28 | 73.98 |
Research and Development Expense of Revenue |
2.41% | — | 3.67% | — | 3.00% | 3.18% | 3.79% | 2.05% | 2.17% | 0.00% |
Selling, General and Administrative Expense of Revenue |
49.65% | — | 50.46% | 0.00% | 66.07% | 62.15% | 48.08% | 46.90% | 34.64% | 30.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.03 | 0.00 | 0.08 | 0.11 | 0.26 | 0.21 | 0.09 | 0.42 |
Share Based Compensation of Revenue |
1.02% | — | 2.09% | — | 19.04% | 16.70% | 5.66% | 5.55% | 13.55% | 9.05% |
Graham Net Nets |
0.08 | — | 0.09 | — | 0.37 | 0.66 | 0.70 | 0.58 | 0.38 | 0.20 |
Graham Number |
0.00 | — | 4.44 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.23 |
Earnings Yield |
0.20% | — | 6.47% | — | (13.27%) | (8.55%) | (11.54%) | (22.17%) | (8.47%) | 10.54% |
Free Cash Flow Yield |
0.00% | — | (0.81%) | — | (2.32%) | (5.85%) | (15.72%) | (13.69%) | (10.78%) | (15.18%) |
Revenue per Share |
1.24 | 0.00 | 0.93 | 0.00 | 1.18 | 1.75 | 2.05 | 3.06 | 1.89 | 2.40 |
Operating CF per Share |
(0.41) | (0.04) | (0.43) | (0.10) | (0.36) | (0.50) | (0.52) | (0.44) | (0.03) | (0.60) |
Capex per Share |
(0.02) | 0.00 | (0.01) | 0.00 | (0.01) | (0.30) | (0.01) | (0.03) | (0.43) | (0.13) |
Free Cash Flow per Share |
(0.43) | (0.04) | (0.44) | (0.10) | (0.37) | (0.80) | (0.53) | (0.47) | (0.46) | (0.73) |
Cash per Share |
10.95 | 0.18 | 0.49 | 0.10 | 7.11 | 6.59 | 2.74 | 2.28 | 1.61 | 0.75 |
Shareholders Equity per Share |
0.00 | 0.70 | 0.44 | 0.61 | 6.79 | 6.79 | 3.85 | 3.19 | 2.86 | 3.40 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.70 | 0.44 | 0.61 | 6.79 | 6.79 | 3.85 | 3.19 | 2.86 | 3.40 |
Free Cash Flow |
(10.91) | (0.26) | (11.19) | (0.79) | (15.91) | (34.51) | (37.86) | (34.32) | (35.50) | (59.92) |
Working Capital |
274.94 | 1.06 | 8.04 | 0.51 | 304.92 | 282.16 | 191.52 | 170.77 | 138.02 | 106.40 |
Capital Expenditures |
(0.60) | — | (0.38) | — | (0.30) | (12.88) | (0.73) | (1.97) | (32.98) | (11.01) |
Net Current Asset Value |
274.94 | (271.26) | 7.74 | (271.94) | 262.28 | 250.43 | 167.59 | 145.62 | 126.01 | 79.79 |
EV/EBIT |
0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | — | 0.02 | — | 0.01 | 0.17 | 0.01 | 0.01 | 0.22 | 0.06 |
Price to Operating Income |
0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | — | 0.30 | — | 0.30 | 0.64 | 2.81 | 2.45 | 0.21 | 0.22 |
Cash ROIC |
(3.96%) | (4.07%) | (47.93%) | (13.59%) | (2.67%) | (6.01%) | (8.06%) | (8.55%) | (10.23%) | (17.60%) |
Accounts Receivable Turnover |
0.00 | — | 9.65 | — | 20.81 | 16.14 | 17.79 | 14.13 | 7.19 | 6.60 |
Accounts Payable Turnover |
0.00 | — | 8.08 | — | 15.21 | 11.22 | 10.81 | 9.06 | 7.09 | 11.00 |
Inventory Turnover |
0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | — | 13.42 | — | 40.85 | 38.31 | 48.74 | 47.57 | 28.71 | 44.78 |
Days of Inventory on Hand |
0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 2.43 | — | 2.43 | 4.66 | 8.21 | 15.94 | 20.41 | 29.89 |
Average Payables |
— | — | 2.61 | — | 2.61 | 5.41 | 11.45 | 20.20 | 16.54 | 14.18 |
Average Assets |
137.58 | 276.43 | 147.70 | 147.78 | 310.62 | 339.64 | 330.45 | 309.98 | 275.81 | 291.07 |
Average Common Equity |
— | 2.89 | 8.04 | 8.04 | 148.11 | 291.30 | 282.93 | 254.39 | 228.12 | 250.51 |
Columns are period end dates · fundamentals updated 5 Nov 2026